🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. Marijuana

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  2. Marijuana via vape device

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 small molecule active

    1 trial

  3. Marinol 10Mg Capsule TMS Sham

    BRIGHT MINDS BIOSCIENCES INC.

    Neurosciences

    phase 1 small molecule completed

    1 trial

  4. Medium THC

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Impairment

    phase 1 small molecule completed

    1 trial

  5. Memantine

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  6. Meningococcal ACYW135 Polysaccharide Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Meningitis, Meningococcal

    phase 1 mab active

    1 trial

  7. Mepolizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  8. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-Related Disorders

    phase 1 small molecule completed

    1 trial

  9. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Stimulant Use

    phase 1 small molecule completed

    1 trial

  10. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Use Disorder

    phase 1 small molecule completed

    1 trial

  11. Methamphetamine (Desoxyn®)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Abuse

    phase 1 small molecule completed

    1 trial

  12. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  13. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 1 small molecule active

    1 trial

  14. Metronidazole gel 1

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  15. Mindful Awareness in Body-oriented Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 1 other completed

    1 trial

  16. Mindfulness Training for Smokers

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 other completed

    1 trial

  17. Mindfulness-Oriented Recovery Enhancement

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 other completed

    1 trial

  18. Minnelide™Capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  19. Modafinil and Escitalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  20. Mometasone furoate drug formulation (MFF) 1

    BRIGHT MINDS BIOSCIENCES INC.

    Hypersensitivity

    phase 1 small molecule completed

    1 trial

  21. Morphine Sulfate

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  22. Motivational Interviewing

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    phase 1 other completed

    1 trial

  23. Motivational Network Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use

    phase 1 other completed

    1 trial

  24. Multi-media WINGS

    BRIGHT MINDS BIOSCIENCES INC.

    Intimate Partner Violence

    phase 1 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources